New Biotech Company, Viela Bio, Launches in Maryland

Karen Glenn Hood

Spin-out of MedImmune’s autoimmunity and inflammation biologics programs will continue development of potential medicines  BALTIMORE, Md. — Viela Bio, a newly-formed spin-out of MedImmune, one of Maryland’s largest life sciences companies and…

Read More »